Listed

Opus Genetics, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Feb 24, 2017 and accepted by EDGAR at Feb 24, 2017, 16:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2016-01-01 to 2016-12-31$10.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-10-01 to 2016-12-31−$3.9mus-gaap:OperatingIncomeLoss
Operating income12 months2016-01-01 to 2016-12-31−$16.4mus-gaap:OperatingIncomeLoss
Net income3 months2016-10-01 to 2016-12-31−$525.5kus-gaap:NetIncomeLoss
Net income12 months2016-01-01 to 2016-12-31−$9.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-10-01 to 2016-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2016-01-01 to 2016-12-31−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2016-01-01 to 2016-12-31−$13.2mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2016-12-31$11.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$20.9mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$21.0mus-gaap:Assets
Total liabilitiesAt period end2016-12-31$4.0mus-gaap:Liabilities
Shareholders' equityAt period end2016-12-31$17.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-17-009132. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.